Genmab A/S (GNMSF) Raw Materials (2023 - 2025)
Genmab A's (GNMSF) quarterly Raw Materials came in at $6.0 million in Q4 2025, up 500.0% YoY from $1.0 million in Q4 2024, and up 500.0% on a QoQ basis from $1.0 million in Q4 2024.
Genmab A/S (GNMSF) Raw Materials (2023 - 2025) Analysis & Trends
Genmab A (GNMSF) has 3 years of Raw Materials data on file, last reported at $6.0 million in Q4 2025.
- Quarterly Raw Materials rose 500.0% year-over-year to $6.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.0 million (up 500.0% YoY) and the FY2025 annual result came in at $6.0 million, up 500.0% from the prior year.
- Raw Materials rose to $6.0 million in Q4 2025, from $1.0 million in the prior quarter.
- In the past five years, Raw Materials ranged from a high of $6.0 million in Q4 2025 to a low of $1.0 million in Q4 2024.
- A 3-year average of $3.0 million and a median of $2.0 million in 2023 frame the typical range for Raw Materials.
- Annual changes were most pronounced in 2024 — Raw Materials sank 50.0% — and 2025, when it soared 500.0%.
- Tracing GNMSF's Raw Materials over 3 years: stood at $2.0 million in 2023, then slumped by 50.0% to $1.0 million in 2024, then soared by 500.0% to $6.0 million in 2025.
- The last three Raw Materials figures came in at $6.0 million (Q4 2025), $1.0 million (Q4 2024), and $2.0 million (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.00 Mn |
| Dec 31, 2024 | 1.00 Mn |
| Dec 31, 2023 | 2.00 Mn |